Phase I Study of Dystrophin Plasmid-Based Gene Therapy in Duchenne/Becker Muscular Dystrophy
✍ Scribed by Romero, Norma B.; Braun, Serge; Benveniste, Olivier; Leturcq, France; Hogrel, Jean-Yves; Morris, Glenn E.; Barois, Annie; Eymard, Bruno; Payan, Christine; Ortega, Véronique; Boch, Anne-Laure; Lejean, Lise; Thioudellet, Christine; Mourot, Brigitte; Escot, Christophe; Choquel, Aurore; Recan, Dominique; Kaplan, Jean-Claude; Dickson, George; Klatzmann, David; Molinier-Frenckel, Valérie; Guillet, Jean-Gérard; Squiban, Patrick; Herson, Serge; Fardeau, Michel
- Book ID
- 120750780
- Publisher
- Mary Ann Liebert
- Year
- 2004
- Tongue
- English
- Weight
- 363 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1043-0342
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Communicated by Ulf Landegren Duchenne and Becker muscular dystrophy (DMD and BMD) are caused by mutations in the dystrophin gene. Large rearrangements in the gene are found in about two-thirds of DMD patients, with B60% carrying deletions and 5-10% carrying duplications. Most of the remaining